Yongjian Wu Email
Chief Development Officer & Head CMC . MBrace Therapeutics
How to contact Yongjian Wu
Join and see Yongjian's contact info for free!Current Roles
Employees:
34Revenue:
$6.4MAbout
MBrace Therapeutics is a privately-held biopharmaceutical company devoted to improving the lives of cancer patients through the development of antibody-drug conjugates (ADCs) against novel oncology targets. MBrace is supported by a world-class investor syndicate, including TPG, Avidity Partners, Cowen Healthcare Investments, Venrock and Alta Partners.MBrace Therapeutics Address
San Diego, CA
United States